Current status of primary liver cancer and decompensated cirrhosis in Japan: launch of a nationwide registry for advanced liver diseases (REAL)
出版年份 2022 全文链接
标题
Current status of primary liver cancer and decompensated cirrhosis in Japan: launch of a nationwide registry for advanced liver diseases (REAL)
作者
关键词
-
出版物
JOURNAL OF GASTROENTEROLOGY
Volume 57, Issue 8, Pages 587-597
出版商
Springer Science and Business Media LLC
发表日期
2022-07-05
DOI
10.1007/s00535-022-01893-5
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Effect of Diameter and Number of Hepatocellular Carcinomas on Survival After Resection, Transarterial Chemoembolization, and Ablation
- (2021) Yoshikuni Kawaguchi et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Report of the 22nd Nationwide Follow‐Up Survey of Primary Liver Cancer in Japan (2012–2013)
- (2021) Masatoshi Kudo et al. HEPATOLOGY RESEARCH
- Evidence‐based clinical practice guidelines for liver cirrhosis 2020
- (2021) Hitoshi Yoshiji et al. HEPATOLOGY RESEARCH
- Evidence-based clinical practice guidelines for Liver Cirrhosis 2020
- (2021) Hitoshi Yoshiji et al. JOURNAL OF GASTROENTEROLOGY
- Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database
- (2021) Jingli Ding et al. BMC CANCER
- Immunotherapies for hepatocellular carcinoma
- (2021) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Molecular therapies for HCC: Looking outside the box
- (2020) Sandrine Faivre et al. JOURNAL OF HEPATOLOGY
- Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
- (2020) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Andrew X Zhu et al. LANCET ONCOLOGY
- Countermeasures against viral hepatitis B and C in Japan: From an epidemiological point of view
- (2019) Junko Tanaka et al. HEPATOLOGY RESEARCH
- Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC Guidelines) a 2019 update
- (2019) Norihiro Kokudo et al. HEPATOLOGY RESEARCH
- Report of the 20th Nationwide Follow‐up Survey of Primary Liver Cancer in Japan
- (2019) Masatoshi Kudo et al. HEPATOLOGY RESEARCH
- Efficacy and safety of rifaximin in Japanese patients with hepatic encephalopathy: A phase II/III, multicenter, randomized, evaluator-blinded, active-controlled trial and a phase III, multicenter, open trial
- (2018) Kazuyuki Suzuki et al. HEPATOLOGY RESEARCH
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
- (2018) Masatoshi Kudo et al. LANCET
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association between institutional procedural preference and in-hospital outcomes in laparoscopic surgeries; Insights from a retrospective cohort analysis of a nationwide surgical database in Japan
- (2018) Hiroaki Miyata et al. PLoS One
- A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011–2015 update
- (2018) Ryosuke Tateishi et al. JOURNAL OF GASTROENTEROLOGY
- Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapy
- (2018) Mizuki Nishibatake Kinoshita et al. JOURNAL OF HEPATOLOGY
- AASLD guidelines for the treatment of hepatocellular carcinoma
- (2017) Julie K. Heimbach et al. HEPATOLOGY
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
- (2017) Masao Omata et al. Hepatology International
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Evidence-based clinical practice guidelines for liver cirrhosis 2015
- (2016) Hiroshi Fukui et al. JOURNAL OF GASTROENTEROLOGY
- Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion
- (2016) Takashi Kokudo et al. JOURNAL OF HEPATOLOGY
- L-carnitine Reduces Muscle Cramps in Patients With Cirrhosis
- (2015) Hiroyuki Nakanishi et al. Clinical Gastroenterology and Hepatology
- Subclassification of BCLC B Stage Hepatocellular Carcinoma and Treatment Strategies: Proposal of Modified Bolondi's Subclassification (Kinki Criteria)
- (2015) Masatoshi Kudo et al. DIGESTIVE DISEASES
- Safety and efficacy of long-term tolvaptan therapy for decompensated liver cirrhosis
- (2015) Tomomi Kogiso et al. HEPATOLOGY RESEARCH
- Tolvaptan for the treatment of liver cirrhosis oedema
- (2014) Isao Sakaida Expert Review of Gastroenterology & Hepatology
- Impact of Histologically Confirmed Lymph Node Metastases on Patient Survival After Surgical Resection for Hepatocellular Carcinoma
- (2013) Kiyoshi Hasegawa et al. ANNALS OF SURGERY
- Overview of the Surveillance, Epidemiology, and End Results Database: Evolution, Data Variables, and Quality Assurance
- (2012) Henry S. Park et al. CURRENT PROBLEMS IN CANCER
- Repeat hepatectomy for recurrent hepatocellular carcinoma: a local experience and a systematic review
- (2010) Yanming Zhou et al. World Journal of Surgical Oncology
- Percutaneous Radiofrequency Ablation Versus Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma: A Retrospective Study
- (2008) Hui-Hong Liang et al. ANNALS OF SURGICAL ONCOLOGY
- Liver cirrhosis
- (2008) Detlef Schuppan et al. LANCET
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started